1. Kramer, Michael H, Zhang, Qiang, Sprung, Robert, Townsend, R Reid, Ley, Timothy J. . Proteomic and phosphoproteomic landscapes of acute myeloid leukemia. In Blood, 140, 1533-1548. doi:10.1182/blood.2022016033. https://pubmed.ncbi.nlm.nih.gov/35895896/
2. Lo, Mindy S. . Monogenic Lupus. In Current rheumatology reports, 18, 71. doi:10.1007/s11926-016-0621-9. https://pubmed.ncbi.nlm.nih.gov/27812953/
3. López-Nevado, Marta, González-Granado, Luis I, Ruiz-García, Raquel, Neth, Olaf, Allende, Luis M. 2021. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. In Frontiers in immunology, 12, 671755. doi:10.3389/fimmu.2021.671755. https://pubmed.ncbi.nlm.nih.gov/34447369/
4. Ke, G, Liang, L, Yang, J M, He, X, Wu, X. 2012. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. In Oncogene, 32, 3019-27. doi:10.1038/onc.2012.323. https://pubmed.ncbi.nlm.nih.gov/22847611/
5. Yang, Qi-En, Ozawa, Manabu, Zhang, Kun, Johnson, Sally E, Ealy, Alan D. . The requirement for protein kinase C delta (PRKCD) during preimplantation bovine embryo development. In Reproduction, fertility, and development, 28, 482-90. doi:10.1071/RD14160. https://pubmed.ncbi.nlm.nih.gov/25116760/
6. Yao, Lijuan, Wang, Li, Li, Fengxia, Wei, Xuegong, Liu, Zhihui. 2015. MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression. In International journal of clinical and experimental medicine, 8, 15198-205. doi:. https://pubmed.ncbi.nlm.nih.gov/26629004/
智鼠故事 
